Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUPROPION HYDROBROMIDE Cause Fibromyalgia? 46 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Fibromyalgia have been filed in association with BUPROPION HYDROBROMIDE (Aplenzin). This represents 19.6% of all adverse event reports for BUPROPION HYDROBROMIDE.

46
Reports of Fibromyalgia with BUPROPION HYDROBROMIDE
19.6%
of all BUPROPION HYDROBROMIDE reports
0
Deaths
38
Hospitalizations

How Dangerous Is Fibromyalgia From BUPROPION HYDROBROMIDE?

Of the 46 reports, 38 (82.6%) required hospitalization.

Is Fibromyalgia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUPROPION HYDROBROMIDE. However, 46 reports have been filed with the FAERS database.

What Other Side Effects Does BUPROPION HYDROBROMIDE Cause?

Headache (82) Asthma (68) Gastrooesophageal reflux disease (64) Therapeutic product effect incomplete (61) Wheezing (59) Hypertension (55) Blood test abnormal (45) Burning sensation (45) Cardiac disorder (45) Carpal tunnel syndrome (45)

What Other Drugs Cause Fibromyalgia?

ADALIMUMAB (4,457) METHOTREXATE (4,131) ETANERCEPT (3,589) TOCILIZUMAB (3,363) ABATACEPT (3,315) LEFLUNOMIDE (3,221) PREDNISONE (3,140) RITUXIMAB (3,065) HYDROXYCHLOROQUINE (3,048) TOFACITINIB (3,031)

Which BUPROPION HYDROBROMIDE Alternatives Have Lower Fibromyalgia Risk?

BUPROPION HYDROBROMIDE vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE BUPROPION HYDROBROMIDE vs BUPROPION\NALTREXONE BUPROPION HYDROBROMIDE vs BUROSUMAB BUPROPION HYDROBROMIDE vs BUROSUMAB-TWZA BUPROPION HYDROBROMIDE vs BUSPIRONE

Related Pages

BUPROPION HYDROBROMIDE Full Profile All Fibromyalgia Reports All Drugs Causing Fibromyalgia BUPROPION HYDROBROMIDE Demographics